Background Despite its clinical benefits, patient compliance to
remote monitoring (RM) of cardiac implantable electronic devices (CIEDs)
varies and remains under-studied in diverse populations.
Objective We sought to evaluate RM compliance, clinical
outcomes, and identify demographic and socioeconomic factors affecting
RM in a diverse urban population in New York. Methods This
retrospective cohort study included patients enrolled in CIED RM at
Montefiore Medical Center between December 2017 and May 2022. RM
compliance was defined as the percentage of days compliant to RM
transmission divided by the total prescribed days of RM. Patients were
censored when they were lost to follow-up or at the time of death. The
cohorts were categorized into low (≤30%), intermediate (31-69%), and
high (≥70%) RM compliance groups. Statistical analyses were conducted
accordingly. Results Among 853 patients, median RM compliance
was 55%. Age inversely affected compliance (p<0.001), and
high compliance was associated with guideline-directed medical therapy
(GDMT) usage and implantable cardioverter defibrillator (ICD)/ cardiac
resynchronization defibrillator (CRTD) devices. The low-compliance group
had a higher mortality rate and fewer regular clinic visits
(p<0.001) than high-compliance group. Socioeconomic factors
did not significantly impact compliance, while Asians showed higher
compliance compared with Whites (OR 3.67; 95% CI 1.08-12.43; p=0.04).
Technical issues were the main reason for non-compliance.
Conclusion We observed suboptimal compliance to RM, which
occurred most frequently in older patients. Clinic visit compliance,
optimal medical therapy, and lower mortality were associated with higher
compliance, whereas insufficient understanding of RM usage was the chief
barrier to compliance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.